Usana Health Sciences (NYSE:USNA) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.37 by 140.54 percent. This is a 126.79 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $213.670 million which missed the analyst consensus estimate of $220.324 million by 3.02 percent. This is a 6.72 percent increase over sales of $200.221 million the same period last year.